Literature DB >> 20038867

Revision rates following primary adult spinal deformity surgery: six hundred forty-three consecutive patients followed-up to twenty-two years postoperative.

Mark A Pichelmann1, Lawrence G Lenke, Keith H Bridwell, Christopher R Good, Patrick T O'Leary, Brenda A Sides.   

Abstract

STUDY
DESIGN: Retrospective study.
OBJECTIVE: To analyze the prevalence of and reasons for unanticipated revision surgery in an adult spinal deformity population treated at one institution. SUMMARY OF BACKGROUND DATA: No recent studies exist that analyze the rate or reason for unanticipated revision surgery for adult spinal deformity patients over a long period.
METHODS: All patients presenting for primary instrumented spinal fusion with a diagnosis of adult deformity at a single institution from 1985 to 2008 were reviewed using a prospectively acquired database. All surgical patients with instrumented fusion of > or =5 levels using hooks, hybrid, or screw-only constructs were identified. Patient charts and radiographs were reviewed to provide information as to the indication for initial and any subsequent reoperation. A total of 643 patients underwent primary instrumented fusion for a diagnosis of adult idiopathic scoliosis (n = 432), de novo degenerative scoliosis (n = 104), adult kyphotic disease (n = 63), or neuromuscular scoliosis (n = 45). The mean age was 37.9 years (range, 18-84). Mean follow-up for the entire cohort was 4.7 years, and 8.2 years for the subset of the cohort requiring reoperation (range, 1 month-22.3 years).
RESULTS: A total of 58 of 643 patients (9.0%) underwent at least one revision surgery and 15 of 643 (2.3%) had more than one revision (mean 1.3; range, 1-3). The mean time to the first revision was 4.0 years (range, 1 week-19.7 years). The most common reasons for revision were pseudarthrosis (24/643 = 3.7%; 24/58 = 41.4%), curve progression (13/643 = 2.0%; 13/58 = 20.7%), infection (9/643 = 1.4%; 9/58 = 15.5%), and painful/prominent implants (4/643 = 0.6%; 4/58 = 6.9%). Uncommon reasons consisted of adjacent segment degeneration (3), implant failure (3), neurologic deficit (1), and coronal imbalance (1). Revision rates over the follow-up period were: 0 to 2 years (26/58 = 44.8%), 2 to 5 years (17/58 = 29.3%), 5 to 10 years (7/58 = 12.1%), >10 years (8/58 = 13.8%).
CONCLUSION: Repeat surgical intervention following definitive spinal instrumented fusion for primary adult deformity performed at a single institution demonstrated a relatively low rate of 9.0%. The most common reasons for revision were predictable and included pseudarthrosis, proximal or distal curve progression, and infection.

Entities:  

Mesh:

Year:  2010        PMID: 20038867     DOI: 10.1097/BRS.0b013e3181c91180

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  40 in total

Review 1.  A systematic review with meta-analysis of posterior interbody fusion versus posterolateral fusion in lumbar spondylolisthesis.

Authors:  Xiaoyang Liu; Yipeng Wang; Guixing Qiu; Xisheng Weng; Bin Yu
Journal:  Eur Spine J       Date:  2013-06-30       Impact factor: 3.134

2.  Risk factors for medical complications after long-level internal fixation in the treatment of adult degenerative scoliosis.

Authors:  Xi-Nuo Zhang; Xiang-Yao Sun; Xiang-Long Meng; Yong Hai
Journal:  Int Orthop       Date:  2018-04-13       Impact factor: 3.075

3.  Reoperation rates in minimally invasive, hybrid and open surgical treatment for adult spinal deformity with minimum 2-year follow-up.

Authors:  D Kojo Hamilton; Adam S Kanter; Bryan D Bolinger; Gregory M Mundis; Stacie Nguyen; Praveen V Mummaneni; Neel Anand; Richard G Fessler; Peter G Passias; Paul Park; Frank La Marca; Juan S Uribe; Michael Y Wang; Behrooz A Akbarnia; Christopher I Shaffrey; David O Okonkwo
Journal:  Eur Spine J       Date:  2016-02-24       Impact factor: 3.134

Review 4.  Stem cells for spine surgery.

Authors:  Joshua Schroeder; Janina Kueper; Kaplan Leon; Meir Liebergall
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

5.  Surgical treatment for adult spinal deformity: projected cost effectiveness at 5-year follow-up.

Authors:  Jamie Terran; Brian J McHugh; Charla R Fischer; Baron Lonner; Daniel Warren; Steven Glassman; Keith Bridwell; Frank Schwab; Virginie Lafage
Journal:  Ochsner J       Date:  2014

6.  Multiple-rod constructs in adult spinal deformity surgery for pelvic-fixated long instrumentations: an integral matched cohort analysis.

Authors:  Fernando Guevara-Villazón; Louis Boissiere; Kazunori Hayashi; Daniel Larrieu; Soufiane Ghailane; Jean-Marc Vital; Olivier Gille; Vincent Pointillart; Ibrahim Obeid; Anouar Bourghli
Journal:  Eur Spine J       Date:  2020-01-28       Impact factor: 3.134

7.  Lack of improvement in health-related quality of life (HRQOL) scores 6 months after surgery for adult spinal deformity (ASD) predicts high revision rate in the second postoperative year.

Authors:  Anouar Bourghli; Louis Boissiere; Daniel Larrieu; Jean-Marc Vital; Caglar Yilgor; Ferran Pellisé; Ahmet Alanay; Emre Acaroglu; Francisco-Javier Perez-Grueso; Franck Kleinstück; Ibrahim Obeid
Journal:  Eur Spine J       Date:  2017-03-30       Impact factor: 3.134

8.  Revision spine surgery in patients without clinical signs of infection: How often are there occult infections in removed hardware?

Authors:  Xiaobang Hu; Isador H Lieberman
Journal:  Eur Spine J       Date:  2018-06-20       Impact factor: 3.134

9.  Proximal Junctional Kyphosis Prevention Strategies: A Video Technique Guide.

Authors:  Michael M Safaee; Joseph A Osorio; Kushagra Verma; Shay Bess; Christopher I Shaffrey; Justin S Smith; Robert Hart; Vedat Deviren; Christopher P Ames
Journal:  Oper Neurosurg (Hagerstown)       Date:  2017-10-01       Impact factor: 2.703

10.  Potential use of (18)F-FDG-PET/CT to visualize hypermetabolism associated with muscle pain in patients with adult spinal deformity: a case report.

Authors:  Yuki Taniguchi; Miwako Takahashi; Ko Matsudaira; Hiroyuki Oka; Toshimitsu Momose
Journal:  Skeletal Radiol       Date:  2016-08-26       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.